FAQ · Layering, storage, allergies

Why do some bergamots cause sun stains?

Cold-pressed bergamot oil carries bergapten, a furanocoumarin that reacts with UVA radiation to produce localized hyperpigmentation. Modern niche perfumery uses bergapten-free (FCF) bergamot.

The essentials

The phenomenon known as sun stains results from a defined photochemical reaction between bergapten, a furanocoumarin naturally present in cold-pressed bergamot oil, and UVA radiation. Bergapten belongs to the psoralen family, flat aromatic molecules with strong affinity for DNA intercalation. When bergapten is on skin and the skin is then exposed to UVA, the molecule inserts between DNA base pairs and the UVA energy drives a covalent crosslinking reaction. The resulting DNA damage triggers an inflammatory and melanogenic response in which melanocytes overproduce melanin at the application site (Perfumer & Flavorist, accessed 2026-05-29).

The clinical presentation, named berloque dermatitis by the German dermatologist Walter Freund in 1925, is a sharply demarcated brown patch, often with the branching shape of a fragrance drip down the neck or chest. The patch develops hours to days after UV exposure rather than immediately, and persists for weeks to months. There is no burning pain, which is why many cases were historically misattributed to other causes before the bergapten mechanism was characterized.

The modern fix is furanocoumarin-free (FCF) bergamot oil, produced by removing the furanocoumarin fraction through molecular or vacuum distillation. FCF bergamot keeps the characteristic linalyl acetate and linalool profile that defines the aromatic identity of the material while eliminating phototoxic risk. The IFRA Standards restrict bergapten in leave-on products to 1 part per million (0.0001 percent), a ceiling so low that FCF bergamot is the only practical option for compliant fine fragrance (IFRA, accessed 2026-05-29).

The photochemistry of bergapten and UVA

Bergapten is 5-methoxypsoralen, a linear furanocoumarin produced by Citrus bergamia and several other rutaceae species. Its planar aromatic structure intercalates between DNA base pairs on contact, and UVA photons in the 320 to 400 nanometer range supply the activation energy for covalent crosslinks between bergapten and thymine residues. The resulting DNA damage activates the same melanogenic signaling that produces a tan, but localized at the area of fragrance contact and amplified by the inflammatory cascade.

The same photochemistry is used therapeutically. PUVA therapy (psoralen plus UVA) treats psoriasis, vitiligo, and certain T-cell lymphomas by applying controlled doses of methoxsalen (8-methoxypsoralen) followed by UVA exposure. The therapeutic and the cosmetic risk share a mechanism; only the dose and the intent differ.

Berloque dermatitis, the clinical picture

Berloque dermatitis presents as hyperpigmented brown patches with a characteristic streak or drip morphology that reflects the path of the original fragrance application. Common locations are the neck, decollete, and inner arms, the areas typically pulse-pointed before outdoor exposure. The reaction follows UVA exposure within 24 to 72 hours, peaks at one to two weeks, and resolves over weeks to months as the epidermis turns over.

The condition is not painful and not itchy in most cases, which distinguishes it clinically from contact dermatitis. Treatment is largely supportive: topical retinoids and hydroquinone preparations can accelerate fading, but the most important intervention is identifying and removing the bergapten source so the cycle does not repeat (Bois de Jasmin, accessed 2026-05-29).

Bergamot in historical perfumery

Bergamot has been a cornerstone of European perfumery since the early 18th century. Eau de Cologne, the format developed by Johann Maria Farina in Cologne in 1709 and codified across the next century, is bergamot-led. Classical chypres of the 20th century, beginning with Francois Coty's Chypre in 1917, also use bergamot at high concentration as their bright opening voice. For most of this history, the phototoxic risk of cold-pressed bergamot was observed empirically without being mechanistically understood.

The identification of bergapten as the responsible compound was published in 1959 by Musajo and colleagues in Farmaco Edizione Scientifica. Through the 1960s and 1970s, photochemical research clarified the dose-response thresholds and the IFRA framework began to take shape. Industrial adoption of FCF bergamot followed in the 1980s and 1990s.

FCF bergamot and the modern formula

FCF bergamot is produced by passing cold-pressed bergamot oil through additional separation steps that strip the furanocoumarin fraction while leaving the more volatile aromatic constituents intact. The resulting material smells indistinguishable from traditional bergamot to most evaluators in finished compositions, since the contributing molecules to the bergamot accord (linalyl acetate, linalool, gamma-terpinene, limonene) are not the furanocoumarins.

EU-market niche perfumery has used FCF bergamot as default since the 1990s. The IFRA 49th and subsequent Amendments have tightened the bergapten ceiling progressively, and modern formulas comply by sourcing FCF material or by limiting cold-pressed bergamot to concentrations below the threshold. The aromatic identity of bergamot in contemporary fine fragrance is therefore preserved without the historical photosensitivity baggage.

Where residual risk still exists

Vintage fragrances formulated before the FCF transition (broadly pre-1990) retain non-trivial bergapten if the original juice has survived. Artisan perfumes formulated outside the IFRA framework, or marketed as natural perfumery without FCF substitution, can also carry phototoxic concentrations. Aromatherapy bergamot essential oil sold to consumers is the most common source of accidental berloque dermatitis today, because consumer-grade oils are often not FCF-specified and lack the warnings printed on fragrance packaging.

The practical position is to verify the FCF status of any direct-to-skin bergamot product before sun-exposed wear, to avoid layering bergamot-heavy artisan compositions before outdoor activity, and to treat any unexplained patchy pigmentation on the neck or chest after a sunny day as a potential bergapten case worth investigating.

Sources

  • International Fragrance Association (IFRA), IFRA Standards on bergapten and furanocoumarin restrictions, 51st Amendment. Accessed 2026-05-29.
  • Perfumer & Flavorist, technical articles on FCF citrus oils, phototoxicity, and reformulation of classical chypres. Accessed 2026-05-29.
  • Bois de Jasmin, Victoria Frolova, editorial coverage of bergamot, eau de cologne history, and modern citrus accords. Accessed 2026-05-29.
  • Musajo, L. et al., identification of bergapten as the phototoxic principle, Farmaco Edizione Scientifica, 1959.
Published 29 May 2026 · Updated 30 May 2026 · Last fact check: 30 May 2026 · Osmetheca · Editorial team